NCI to Fund Consortium to Characterize Lesions at Molecular, Cellular Level | GenomeWeb

NEW YORK (GenomeWeb) – The National Cancer Institute will provide up to $4.5 million next year to fund research teams performing omics studies to characterize tumor lesions discovered through screening, with the aim of better predicting which lesions are progressive and require interventions and which are indolent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?